Depression Neurobiology and Treatment: The Role of GABA and Neurosteroids

Distance Training Glossary | Print Version | Email This Page To A Friend

Training Details

Event Dates and Timeframe
Any Time
Location and Delivery Method
Delivery Method
Online / Web Delivered
Cost Range
FREE
Provided by North American Center for Continuing Medical Education, LLC (NACCME), an HMP Global Company. NACCME would like to thank the following company/companies who has/have supported "Depression Neurobiology and Treatment: The Role of GABA and Neurosteroids " through educational grants and/or in-kind support: Sage Therapeutics, Inc.

Host And Instructor

Host
Psychiatry & Behavioral Health Learning Network
Instructor
Vladimir Maletic, MD, MS
class/provider logo image

Credits

C.E. Credit for Consult with Training Provider for CE specifcs: 0.75
Specialization: 0.75 APA 0.75 CME 0.75 CNE 0.75 Participation 0.75 Social Worker
This session was previously presented at Elevate 2021. If you claimed credit for this session at Elevate 2021, you are not eligable to claim credit for this session again.

Training Overview Description

We would like to invite you to participate in this new webcast on the role of GABA and neurosteroids in the treatment of depression.

This accredited, on-demand activity features a presentation that discusses the latest research updates regarding the neurobiological mechanisms of MDD and PPD and implications for therapeutic targeting.

INTENDED LEARNERS
This activity is designed for psychiatrists, primary care physicians, psychologists, nurse practitioners, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.

LEARNING OBJECTIVES
After participating in this activity, learners should be better able to:

  • Analyze causes of MDD and PPD undertreatment, limitations of current pharmacological agents, and implications for patient morbidity and mortality
  • Discuss research updates regarding the neurobiological mechanisms of MDD and PPD and implications for therapeutic targeting
  • Analyze the mechanisms of action and safety and efficacy data for new and emerging MDD and PPD therapies

Event-specific Details

In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

0.75 APA
0.75 CME
0.75 CNE
0.75 Participation
0.75 Social Worker

Registration Information

CLICK HERE TO REGISTER for Depression Neurobiology and Treatment: The Role of GABA and Neurosteroids

Funding: Grant funded by the Alaska Mental Health Trust Authority through the University of Alaska Anchorage Center for Human Development.

UAA is an AA/EO employer and educational institution and prohibits illegal discrimination against any individual: http://alaska.edu/titleIXcompliance/nondiscrimination

UA is committed to providing accessible websites. Learn more about UA's notice of web accessibility.